Contract Notice Detail
Summary Information
Summary Information
Base Total Price:
195,752.511550 Euro
Request Reference:
06/02378.11/2024 - Aq. de vários medicamentos
Request Name:
06/02378.11/2024 - Aquisição de vários medicamentos ao abrigo do Acordo Quadro nº 2023/491
Phase:
Tendering Phase
State:
Awarded
Description:
06/02378.11/2024 - Aquisição de vários medicamentos ao abrigo do Acordo Quadro nº 2023/491
Procedure Type:
VortalGOV - Acquisition under a Framework Agreement (via Direct Award)
Lot Name
Lot Base Price
Expected Duration
A5027 - ANACINRA [100 MG/0.67 ML; SOL INJ; F/SERINGA]
-
7
(
Months
)
C1004 - CLADRIBINA (SOL INJ) [2 MG/ML; FRS 5 ML]
-
7
(
Months
)
R1045 - RIBOCICLIB [200 MG; CÁP/ COMP]
-
7
(
Months
)
T1572 - TRAMETINIB [2 MG; CÁP/ COMP]
-
7
(
Months
)
Object of the Contract
Object of the Contract
Type of Contract:
Supplies Acquisition
Main Object CPV Main Category:
Rua Dr. Cândido Pinho 4520 211 PORTUGAL
CPV Main Vocabulary
33600000-6 - Pharmaceutical products
CPV Supplementary Vocabulary
Additional Classifications List
Scheduling
Scheduling
Request online publishing date:
6/7/2024 3:56 PM
(UTC +1 hour)
National official publishing date and time (DR):
9/4/2023 3:37 PM
(UTC +1 hour)
Due datetime for receiving replies:
6/12/2024 5:00 PM
(UTC +1 hour)
Financial Settings
Financial Settings
Define Warranties?
No
Contract Documents
Contract Documents
Document Name
Description
Doc Classification
Anexo III.xlsx
Anexo III.xlsx
Download
Convite e CE 06_02310.11_2024.pdf
Convite e CE 06_02310.11_2024.pdf
Download
Object of contract
This contract is subject to renewal?
No
The procurement is related to a project and/or programme financed by European Union funds?
No
Legal, economic, financial and technical information
The contract is reserved to sheltered workshops and economic operators aiming at the social and professional integration of disabled or disadvantaged persons?
No
Questionnaire
Questionnaire
1
Lot Title
A5027 - ANACINRA [100 MG/0.67 ML; SOL INJ; F/SERINGA]
Base Price
24.125,714000
1.1
Bill of Quantities
*
This price list has extra requirements. Make sure everything is completed, under each article line.
Item Code
Description
Quantity
Unit
A5027
ANACINRA [100 MG/0.67 ML; SOL INJ; F/SERINGA]
1.000,000000
NXTWY.UMT.13087
Buyer Comment:
500223238 | Profarin - Distribuidora Produtos Farmacêuticos Industriais, Lda. | CPA:2023491/210/0156 | NºAIM:5591342;
TOTAL
(The amounts shown do not include VAT)
2
Lot Title
C1004 - CLADRIBINA (SOL INJ) [2 MG/ML; FRS 5 ML]
Base Price
5.365,400000
2.1
Bill of Quantities
*
This price list has extra requirements. Make sure everything is completed, under each article line.
Item Code
Description
Quantity
Unit
C1004
CLADRIBINA (SOL INJ) [2 MG/ML; FRS 5 ML]
20,000000
NXTWY.UMT.13087
Buyer Comment:
507002571 | Pharmakern Portugal, Produtos Farmacêuticos Soc. Unipessoal, Lda. | CPA:2023491/379/0415 | NºAIM:5055686;
TOTAL
(The amounts shown do not include VAT)
3
Lot Title
R1045 - RIBOCICLIB [200 MG; CÁP/ COMP]
Base Price
130.957,397550
3.1
Bill of Quantities
*
This price list has extra requirements. Make sure everything is completed, under each article line.
Item Code
Description
Quantity
Unit
R1045
RIBOCICLIB [200 MG; CÁP/ COMP]
4.410,000000
NXTWY.UMT.13087
Buyer Comment:
500063524 | Novartis Farma - Produtos Farmacêuticos, S.A. | CPA:2023491/128/0353 | NºAIM:5725858; 500063524 | Novartis Farma - Produtos Farmacêuticos, S.A. | CPA:2023491/128/0354 | NºAIM:5725866;
TOTAL
(The amounts shown do not include VAT)
4
Lot Title
T1572 - TRAMETINIB [2 MG; CÁP/ COMP]
Base Price
35.304,000000
4.1
Bill of Quantities
*
This price list has extra requirements. Make sure everything is completed, under each article line.
Item Code
Description
Quantity
Unit
T1572
TRAMETINIB [2 MG; CÁP/ COMP]
300,000000
NXTWY.UMT.13087
Buyer Comment:
500063524 | Novartis Farma - Produtos Farmacêuticos, S.A. | CPA:2023491/128/0362 | NºAIM:5653456;
TOTAL
(The amounts shown do not include VAT)
Evaluation
Evaluation
Vision
Avaliação
Definir modelo de avaliação
Sim
Não
Modalidade de avaliação
Selecione…
Monofator
Método de Avaliação
Selecione…
Manual
Divulgar critérios de avaliação
Sim
Não
Critérios da Avaliação
1 - A5027 - ANACINRA [100 MG/0.67 ML; SOL INJ; F/SERINGA]
Critérios da Avaliação
Descrição
Tipo de Fator
Peso (%)
1.
Preço
Preço
100%
Normas de desempate
Definir normas de desempate?
Sim
Não
Normas de desempate
Nível
Tipo de Norma
Descrição
Critério
1
Sorteio
Sorteio
-
2 - C1004 - CLADRIBINA (SOL INJ) [2 MG/ML; FRS 5 ML]
Critérios da Avaliação
Descrição
Tipo de Fator
Peso (%)
1.
Preço
-
100%
Normas de desempate
3 - R1045 - RIBOCICLIB [200 MG; CÁP/ COMP]
Critérios da Avaliação
Descrição
Tipo de Fator
Peso (%)
1.
Preço
-
100%
Normas de desempate
4 - T1572 - TRAMETINIB [2 MG; CÁP/ COMP]
Critérios da Avaliação
Descrição
Tipo de Fator
Peso (%)
1.
Preço
-
100%
Normas de desempate
Public Messages
Public Messages
Type
Reference
Subject
Date
No items found...